MSLN and pancreatic neoplasm: In contrast, the vaccine CRS-207 contains the live attenuated pathogen Listeria monocytogenes, which stimulate an immune response against mesothelin, a tumor-associated antigen overproduced by the pancreatic tumor [128,129].